{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:34:21Z","timestamp":1793878461802,"version":"4.7.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.vaccine.2013.04.027","type":"journal-article","created":{"date-parts":[[2013,4,23]],"date-time":"2013-04-23T18:42:06Z","timestamp":1366742526000},"page":"2804-2810","source":"Crossref","is-referenced-by-count":81,"title":["Liposomes containing monophosphoryl lipid A: A potent adjuvant system for inducing antibodies to heroin hapten analogs"],"prefix":"10.1016","volume":"31","author":[{"given":"Gary R.","family":"Matyas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander V.","family":"Mayorov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenner C.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur E.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malliga R.","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim D.","family":"Janda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl R.","family":"Alving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.04.027_bib0005","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1586\/erv.10.142","article-title":"Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens","volume":"10","author":"Dey","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"10.1016\/j.vaccine.2013.04.027_bib0010","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.coi.2012.03.008","article-title":"Adjuvants for human vaccines","volume":"24","author":"Alving","year":"2012","journal-title":"Curr Opin Immunol"},{"issue":"13","key":"10.1016\/j.vaccine.2013.04.027_bib0015","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.vaccine.2012.01.070","article-title":"Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens","volume":"16","author":"Watson","year":"2012","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2013.04.027_bib0020","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1586\/erv.12.35","article-title":"Liposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccines","volume":"11","author":"Alving","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2013.04.027_bib0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1995.tb00075.x","article-title":"Liposomes as carriers of peptide antigens: induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides","volume":"145","author":"Alving","year":"1995","journal-title":"Immunol Rev"},{"issue":"4","key":"10.1016\/j.vaccine.2013.04.027_bib0030","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1073\/pnas.022627199","article-title":"A liposome-based therapeutic vaccine against beta -amyloid plaques on the pancreas of transgenic NORBA mice","volume":"99","author":"Nicolau","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"10.1016\/j.vaccine.2013.04.027_bib0035","doi-asserted-by":"crossref","first-page":"13966","DOI":"10.1074\/jbc.M110.186338","article-title":"Sequence-independent control of peptide conformation in liposomal vaccines for targeting protein misfolding diseases","volume":"286","author":"Hickman","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2013.04.027_bib0040","series-title":"The specificity of serological reactions","author":"Landsteiner","year":"1945"},{"issue":"2","key":"10.1016\/j.vaccine.2013.04.027_bib0045","first-page":"103","article-title":"The immunological assay of drugs","volume":"29","author":"Butler","year":"1977","journal-title":"Pharmacol Rev"},{"issue":"1-2","key":"10.1016\/j.vaccine.2013.04.027_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2011.02.011","article-title":"Applications and recent developments of multi-analyte simultaneous analysis by enzyme-linked immunosorbent assays","volume":"368","author":"Zhang","year":"2011","journal-title":"J Immunol Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2013.04.027_bib0055","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pharmthera.2005.06.009","article-title":"Immunotherapy for the treatment of drug abuse","volume":"108","author":"Kosten","year":"2005","journal-title":"Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.vaccine.2013.04.027_bib0060","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/icb.2009.17","article-title":"Anti-drug vaccines to treat substance abuse","volume":"87","author":"Kinsey","year":"2009","journal-title":"Immunol Cell Biol"},{"issue":"1","key":"10.1016\/j.vaccine.2013.04.027_bib0065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nri3130","article-title":"Vaccines targeting drugs of abuse: is the glass half-empty or half-full?","volume":"12","author":"Janda","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2013.04.027_bib0070","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2011.281","article-title":"Vaccines against drug abuse","volume":"91","author":"Shen","year":"2012","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.vaccine.2013.04.027_bib0075","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1021\/bi00705a003","article-title":"Antibody formation in response to liposomal model membranes sensitized with N-substituted phosphatidylethanolamine derivatives","volume":"13","author":"Uemura","year":"1974","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.vaccine.2013.04.027_bib0080","first-page":"281","article-title":"Antibodies to morphine, barbiturates, and serotonin","volume":"25","author":"Spector","year":"1973","journal-title":"Pharmacol Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2013.04.027_bib0085","first-page":"514","article-title":"Specificities of antibodies to morphine","volume":"180","author":"Van Vunakis","year":"1972","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.vaccine.2013.04.027_bib0090","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0090-1229(74)90001-4","article-title":"Immunochemical studies of opioids: specificities of antibodies against codeine and hydromorphone","volume":"3","author":"Wainer","year":"1974","journal-title":"Clin Immunol Immunopathol"},{"issue":"5485","key":"10.1016\/j.vaccine.2013.04.027_bib0095","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/252708a0","article-title":"Changes in heroin self-administration by a rhesus monkey after morphine immunization","volume":"252","author":"Bonese","year":"1974","journal-title":"Nature"},{"issue":"1-2","key":"10.1016\/j.vaccine.2013.04.027_bib0100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0022-1759(93)90080-Q","article-title":"Characterization of morphine-specific monoclonal antibodies showing minimal cross-reactivity with codeine","volume":"157","author":"Usagawa","year":"1993","journal-title":"J Immunol Methods"},{"issue":"16","key":"10.1016\/j.vaccine.2013.04.027_bib0105","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.vaccine.2006.01.047","article-title":"A novel bivalent morphine\/heroin vaccine that prevents relapse to heroin addiction in rodents","volume":"24","author":"Anton","year":"2006","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2013.04.027_bib0110","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1021\/jm200461m","article-title":"A vaccine strategy that induces protective immunity against heroin","volume":"54","author":"Stowe","year":"2011","journal-title":"J Med Chem"},{"issue":"27","key":"10.1016\/j.vaccine.2013.04.027_bib0115","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1016\/j.vaccine.2007.04.078","article-title":"Imject Alum is not aluminum hydroxide adjuvant or aluminum phosphate adjuvant","volume":"25","author":"Hem","year":"2007","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2013.04.027_bib0120","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3923\/pjbs.2010.1047.1051","article-title":"Safety of human therapeutic morphine vaccine employing Lohmann specific pathogen free eggs","volume":"13","author":"Farhangi","year":"2010","journal-title":"Pak J Biol Sci"},{"issue":"12","key":"10.1016\/j.vaccine.2013.04.027_bib0125","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1021\/js9601593","article-title":"Liposomal subunit vaccines: effects of lipid A and aluminum hydroxide on immunogenicity","volume":"85","author":"Richards","year":"1996","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.vaccine.2013.04.027_bib0130","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.vaccine.2010.11.049","article-title":"Highly effective generic adjuvant systems for orphan or poverty-related vaccines","volume":"29","author":"Rao","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.04.027_bib0135","series-title":"Fmoc solid phase peptide synthesis: a practical approach","year":"2000"},{"key":"10.1016\/j.vaccine.2013.04.027_bib0140","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/cber.19701030319","article-title":"Eine neue Methode zur Synthese von Peptiden: Aktivierung der Carboxylgruppe mit Dicyclohexylcarbodiimid unter Zusatz von 1-Hydroxy-benzotriazolen","volume":"103","author":"K\u00f6nig","year":"1970","journal-title":"Chemische Berichte"},{"key":"10.1016\/j.vaccine.2013.04.027_bib0145","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1021\/jo00046a022","article-title":"Optimization of solid-phase synthesis of [Ala8]-dynorphin A","volume":"57","author":"Sole","year":"1992","journal-title":"J Org Chem"},{"key":"10.1016\/j.vaccine.2013.04.027_bib0150","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0076-6879(03)73003-1","article-title":"Oil-in water liposomal emulsions for vaccine delivery","volume":"373","author":"Matyas","year":"2003","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.vaccine.2013.04.027_bib0155","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1097\/QAD.0b013e32832faea5","article-title":"Neutralizing antibodies induced by liposomal HIV-1 gp41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes","volume":"23","author":"Matyas","year":"2009","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.vaccine.2013.04.027_bib0160","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1073\/pnas.85.6.1902","article-title":"Antibodies to cholesterol","volume":"85","author":"Swartz","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.vaccine.2013.04.027_bib0165","first-page":"441","article-title":"GM Antibodies to cholesterol, cholesterol conjugates and liposomes: implications for atherosclerosis and autoimmunity","volume":"10","author":"Alving","year":"1991","journal-title":"Crit Rev Immunol"},{"issue":"34","key":"10.1016\/j.vaccine.2013.04.027_bib0170","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1016\/j.vaccine.2009.05.059","article-title":"Role of lipid structure in the humoral immune response in mice to covalent lipid-peptides from the membrane proximal region of HIV-1 gp41","volume":"27","author":"Watson","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.04.027_bib0175","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.1021\/bi050262j","article-title":"2.3 \u00c5 crystal structure of tetanus neurotoxin light chain","volume":"44","author":"Breidenbach","year":"2005","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.vaccine.2013.04.027_bib0180","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4161\/hv.5.4.7556","article-title":"Vaccines against morphine\/heroin and its use as effective medication for preventing relapse to opiate addictive behaviors","volume":"5","author":"Anton","year":"2009","journal-title":"Hum Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2013.04.027_bib0185","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1073\/pnas.98.4.1988","article-title":"A second-generation vaccine protects against the psychoactive effects of cocaine","volume":"98","author":"Carrera","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2013.04.027_bib0190","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00213-005-0027-2","article-title":"Effects of a nicotine conjugate vaccine on the acquisition and maintenance of nicotine self-administration in rats","volume":"184","author":"LeSage","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"10.1016\/j.vaccine.2013.04.027_bib0195","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/j.1471-4159.2011.07502.x","article-title":"A morphine\/heroin vaccine with new hapten design attenuates behavioral effects in rats","volume":"119","author":"Li","year":"2011","journal-title":"J Neurochem"},{"key":"10.1016\/j.vaccine.2013.04.027_bib0200","series-title":"Fundamental Immunology","first-page":"631","article-title":"Immunogenicity and antigen structure","author":"Berzofsky","year":"2008"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13004660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13004660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T23:50:27Z","timestamp":1562975427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13004660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":40,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0264410X13004660"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.04.027","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}